Health and Human Services Department, Food and Drug Administration
The Food and Drug Administration (FDA) is confirming the effective date of December 14, 2022, for the final rule that appeared in the Federal Register of September 15, 2022. The direct final rule revises the "small number of animals" definition for dogs and cats in our existing regulation for new animal drugs for minor use or minor species. This document confirms the effective date of the direct final rule.
Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Health and Human Services Food and Drug Administration 21 CFR Part 516 [Docket No. FDA-2022-N-1128] AGENCY: Food and Drug Administration, HHS. ACTION: Direct final rule; confirmation of effective date. SUMMARY: The Food and Drug Administration (FDA) is confirming the effective date of December 14, 2022, for the final rule that appeared in the Federal Register of September 15, 2022. The direct final rule revises the “small number of animals” definition for dogs and cats in our existing regulation for new animal drugs for minor use or minor species. This document confirms the effective date of the direct final rule. DATES: The effective date of December 14, 2022, for the direct final rule published September 15, 2022 ( 87 FR 56583 ) is confirmed. FOR FURTHER INFORMATION CONTACT: Janah Maresca, Center for Veterinary Medicine (HVF-50), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-796-5079, email: janah.maresca@fda.hhs.gov . SUPPLEMENTARY INFORMATION: In the Federal Register of September 15, 2022 ( 87 FR 56583 ), FDA solicited comments concerning the direct final rule for a 60-day period ending November 14, 2022. FDA stated that the effective date of the direct final rule would be on December 14, 2022, 30 days after the end of the comment period, unless any significant adverse comment was submitted to FDA during the comment period. FDA did not receive any significant adverse comments. Authority: 21 U.S.C. 360ccc-1 , 360ccc-2 ,…
Other Federal Register documents from the same docket.
Citation: 87 FR 76425
